BIOY vs QYLD
GraniteShares YieldBOOST Biotech ETF against Global X Funds Global X NASDAQ-100 Covered Call ETF: cost, size, returns, what they hold and how much of it is the same.
Fee gap
47 bp
QYLD is cheaper
1-year return gap
—
Larger fund
QYLD
$8.5B
Side by side
| BIOY | QYLD | |
|---|---|---|
| Fund | GraniteShares YieldBOOST Biotech ETF | Global X Funds Global X NASDAQ-100 Covered Call ETF |
| Issuer | GraniteShares | Global X |
| Category | Covered Call | Covered Call |
| Expense ratio | 1.07% | 0.60% |
| Assets | $693K | $8.5B |
| Average daily dollar volume | $46K | $69M |
| Listed | May 4, 2026 | Dec 11, 2013 |
| FrenzyCap score | 5 | 82 |
| 1-month return | −2.9% | +2.5% |
| 3-month return | −9.8% | +3.0% |
| Year to date | — | +5.8% |
| 1-year return | — | +8.9% |
| 30-day volatility | 18.7% | 5.6% |
| Worst drawdown, 1 year | −21.1% | −7.0% |
| Trailing 12-month yield | 29.11% | 11.40% |
| Holdings | 3 | 104 |
| Top 10 weight | 58.6% | 49.2% |
| Look-through P/E | — | 35.0 |
| Holdings vs fair value | — | −4.8% |
| Holdings above 200-day average | — | 79% |
| Net flow, latest 3 reported months | +$750K thru Jun 2026 | −$250M thru Jul 2026 |
| 30-day implied volatility | — | 15.8% |
| Holdings as of | as of Jun 30, 2026SEC filing | as of Oct 9, 2026issuer data |
Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.
More: full overlap table · BIOY holdings · QYLD holdings
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.